11 completed, 8 unknown, 5 active not recruiting, 5 recruiting. 9 Not applicable, 5 Phase 2, 3 Phase 4, 2 Phase 3, 1 Early Phase 1.
Follow Alveolitis, Extrinsic Allergic: new trials by email Literature Review of Alveolitis, Extrinsic Allergic trials Research Report on Alveolitis, Extrinsic Allergic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD Gabapentin, Benzonatate 200 mg, Standard of care treatment for ILD - Interstitial Lung Disease | Phase 4 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 177 | 2026-10-07 | 2026-10-08 |
| "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis" Prednisolone, Placebo - Hypersensitivity Pneumonitis | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 120 | 2026-06-01 | 2025-10-07 |
| Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases. standard interview - Interstitial Lung Disease Due to Systemic Disease (Disorder), Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder) | Active not recruiting | Istituto Clinico Humanitas | 1000 | 2026-04-01 | 2026-05-11 | |
| Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP), Staying Well - Hypersensitivity Pneumonitis | Not applicable | Recruiting | Weill Medical College of Cornell University | 42 | 2025-05-06 | 2026-10-16 |
| Skeletal Muscle Function in Interstitial Lung Disease Hyperoxia - Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis | Not applicable | Recruiting | University of British Columbia | 40 | 2024-08-07 | 2026-05-15 |
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis AP01, Placebo - Pulmonary Fibrosis, Progressive Pulmonary Fibrosis | Phase 2 | Active not recruiting | Avalyn Pharma Inc. | 398 | 2024-04-03 | 2026-10-16 |
| Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis Hypersensitivity Pneumonitis | Recruiting | Nantes University Hospital | 100 | 2023-11-16 | 2026-10-16 | |
| Hypersensitivity Pneumonitis of Domestic Origin blood sample - Sensitisation, Mold or Dust Allergy | Not applicable | Unknown | Centre Hospitalier Universitaire de Besancon | 500 | 2023-02-01 | 2023-01-30 |
| Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases Breath test using the Compact PTR-TOF-MS, Portable cardiac monitor "CardioQvark", Assessment of arterial stiffness using the VaSera VS-1500N - Chronic Respiratory Diseases, Cystic Fibrosis | Enrolling by invitation | I.M. Sechenov First Moscow State Medical University | 400 | 2023-01-30 | 2024-07-30 | |
| An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis Mycophenolate Mofetil plus prednisolone, Prednisolone - Hypersensitivity Pneumonitis | Phase 4 | Active not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 144 | 2022-11-23 | 2026-06-03 |
| Prognostic Score Comparison in IPF and HP GAP Index, ILD-GAP Index, Composite Physiologic Index (CPI) - IPF, Fibrotic Lung Disease | Completed | Saglik Bilimleri Universitesi | 143 | 2022-10-01 | 2025-09-11 | |
| Database and Biobank of Patients With Hypersensitivity Pneumonitis Hypersensitivity Pneumonitis | Recruiting | Nils Hoyer | 50 | 2022-09-18 | 2023-12-22 | |
| Patient-Reported Outcome Study of Project ECHO for ILD Interstitial Lung Disease | Unknown | Pulmonary Care and Research Collaborative Limited | 56 | 2022-07-01 | 2022-07-08 | |
| Monitoring and Evaluation Study of Project ECHO for ILD Interstitial Lung Diseases | Unknown | Pulmonary Care and Research Collaborative Limited | 200 | 2022-07-01 | 2022-07-13 | |
| Pulmonary Care and Research Collaborative Patient Registry Interstitial Lung Disease | Unknown | Pulmonary Care and Research Collaborative Limited | 150 | 2022-07-01 | 2022-07-19 | |
| HypErsensitiVity PneumonITis: DiseAse Progression Characterization Disease assessment - Hypersensitivity Pneumonitis | Unknown | Hospital do Coracao | 150 | 2022-06-20 | 2023-06-29 | |
| 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study Hyperpolarized Xe129 - Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis | Phase 2 | Withdrawn | University of Kansas Medical Center | 2022-05-01 | 2022-09-10 | |
| FAPI PET for Lung Fibrosis 68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography - Interstitial Lung Disease, Idiopathic Interstitial Pneumonias | Early Phase 1 | Active not recruiting | University of California, Los Angeles | 30 | 2021-11-16 | 2026-08-20 |
| Interstitial Lung Disease Research Unit Biobank Interstitial Lung Disease, Sarcoidosis | Recruiting | University of Kansas Medical Center | 1000 | 2021-08-09 | 2026-07-10 | |
| Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis nasal endoscopy - Hypersensitivity Pneumonitis, Nasal Mucosal Disorder | Not applicable | Completed | Cairo University | 40 | 2021-07-01 | 2023-02-13 |
Showing 20 of 35. Sign in to see all of them.
Lung Diseases, Interstitial (16) · Idiopathic Pulmonary Fibrosis (10) · Pulmonary Fibrosis (9) · Sarcoidosis (6) · Idiopathic Interstitial Pneumonias (3) · Bird Fancier's Lung (2) · Disease (2) · Asthma (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Cough (1) · Cystic Fibrosis (1) · Hypertension, Pulmonary (1) · Lymphangioleiomyomatosis (1)
Hypersensitivity (35) · Hypersensitivity, Immediate (35) · Immune System Diseases (35) · Lung Diseases (35) · Respiratory Hypersensitivity (35) · Respiratory Tract Diseases (35) · Lung Diseases, Interstitial (19) · Pathologic Processes (12) · Pathological Conditions, Signs and Symptoms (12) · Fibrosis (9) · Hemic and Lymphatic Diseases (7) · Lymphatic Diseases (7) · Lymphoproliferative Disorders (7) · Hypersensitivity, Delayed (6) · Pulmonary Fibrosis (6)
Blood Specimen Collection (4) · Prednisolone (3) · pirfenidone (2) · Albuterol (1) · Bronchoscopy (1) · Educational Status (1) · Excipients (1) · FAPI-46 (1) · Gabapentin (1) · Genome (1) · Magnetic Resonance Spectroscopy (1) · Methods (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Palliative Care (1)
Centre Hospitalier Universitaire de Besancon (3) · Pulmonary Care and Research Collaborative Limited (3) · Cairo University (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · University of Kansas Medical Center (2) · Weill Medical College of Cornell University (2) · Al-Azhar University (1) · Assistance Publique - Hôpitaux de Paris (1) · Avalyn Pharma Inc. (1) · Bossink, A.W.J. (1) · Gazi University (1) · Grupo Medifarma, S. A. de C. V. (1) · Hospital do Coracao (1) · I.M. Sechenov First Moscow State Medical University (1) · Istituto Clinico Humanitas (1)
United States (11) · Egypt (4) · France (4) · Argentina (2) · Brazil (2) · Canada (2) · Germany (2) · India (2) · Italy (2) · Netherlands (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Australia (1) · Belgium (1) · Chile (1)
Aliaa Barakat, PhD (3) · Kerri I Aronson, MD (2) · Sahajal Dhooria, MD, DM (2) · Aik Bossink, MD PhD (1) · Francesco Amati, MD (1) · Imre Noth, MD (1) · Jeremie Calais, MD (1) · Jordan A Guenette, PhD (1) · Laurence Millon (1) · Leticia Kawano Dourado, MD (1)
PMID 12842854, PMID 1414806, PMID 16166619, PMID 18096541, PMID 20822994, PMID 28760669, PMID 31784348, PMID 3371127, PMID 34048641, PMID 36759788, PMID 36948586, PMID 37258647, PMID 39362770, PMID 41448793, PMID 7676971
2025 (1), K23HL163394 (1)